Fred M. Powell

Chief Financial Officer

US·SEC (Form 4)

Antares Pharma, Inc.LAVA Therapeutics NV

Cumul. flow

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 17 Nov 2025 for LAVA Therapeutics NV. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Fred M. Powell: trading record in brief

Fred M. Powell is a declared insider at 2 companies (finance chief); the most frequent names are Antares Pharma, Inc. and LAVA Therapeutics NV. Over a trading history stretching from 8 June 2021 to 13 November 2025, the count stands at 6 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 17 November 2025, reports a transaction in LAVA Therapeutics NV. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.